<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/42CFR405.html">Part 405
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 405.211  Coverage of items and services in FDA-approved IDE studies.
                            </h3>
                            <p class="depth1"><em>(a)</em> Coverage of routine care items and services for Category A (Experimental) devices. Medicare covers routine care items and services furnished in an FDA-approved Category A (Experimental) IDE study if CMS (or its designated entity) determines that the Medicare coverage IDE study criteria in Sec. 405.212 are met.</p><p class="depth1"><em>(b)</em> Coverage of Category B (Nonexperimental/investigational) IDE devices and routine care items and services. Medicare may make payment for a Category B (Nonexperimental/investigational) IDE device and routine care items and services furnished in an FDA-approved Category B (Nonexperimental/investigational) IDE study if CMS (or its designated entity) determines prior to the submission of the first related claim that the Medicare coverage IDE study criteria in Sec. 405.212 are met.</p><p class="depth1"><em>(c)</em> CMS (or its designated entity) must review the following to determine if the Medicare coverage IDE study criteria in Sec. 405.212 are met for purposes of

coverage of items and services described in paragraphs (a) and (b) of this section:</p><p class="depth2"><em>(1)</em> FDA approval letter of the IDE.</p><p class="depth2"><em>(2)</em> IDE study protocol.</p><p class="depth2"><em>(3)</em> IRB approval letter.</p><p class="depth2"><em>(4)</em> NCT number.</p><p class="depth2"><em>(5)</em> Supporting materials, as needed.</p><p class="depth1"><em>(d)</em> Notification. A listing of all CMS-approved Category A (Experimental) IDE studies and Category B (Nonexperimental/investigational) IDE studies shall be posted on the CMS Web site and published in the Federal Register.
[78 FR 74809, Dec. 10, 2013]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
